Inactive Instrument
Eurofins Cerep Share Price Euronext Paris
Stocks
FR0012045946
Biotechnology & Medical Research
|
End-of-day quote
Euronext Paris
|
||
| - EUR | - |
|
| 08-25 | Lotus Bakeries, the most expensive speculoos on the (stock) market in Europe |  |
| 04-29 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 91.8M 107M 86.07M 78.57M 148M 10.18B 148M 1.02B 398M 5.14B 400M 391M 17.04B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 70.77M 82.12M 66.35M 60.57M 114M 7.85B 114M 787M 307M 3.96B 308M 302M 13.14B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 10/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 10/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 22/05/2024 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.98% | -1.53% | +1.37% | +18.39% | 50.47B | |
| -6.00% | -0.75% | +447.48% | +524.26% | 44.56B | |
| -0.24% | +0.74% | +37.18% | +16.57% | 43.08B | |
| -1.55% | -2.07% | +19.83% | +73.63% | 41.7B | |
| -0.31% | -0.83% | +19.47% | +48.24% | 33.21B | |
| -1.79% | -3.24% | +26.32% | +121.63% | 16.77B | |
| -0.58% | -2.12% | - | - | 16.28B | |
| -0.11% | -1.34% | +11.23% | +27.16% | 14.58B | |
| -1.66% | -1.25% | +78.49% | +39.02% | 13.92B | |
| Average | -1.47% | -1.39% | +80.17% | +108.61% | 30.51B | |
| Weighted average by Cap. | -1.70% | -1.21% | +95.94% | +126.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 46.99M 37.96M 34.65M 65.28M 4.49B 65.49M 450M 176M 2.27B 176M 173M 7.52B | 41.1M 47.7M 38.53M 35.18M 66.27M 4.56B 66.48M 457M 178M 2.3B 179M 175M 7.63B |
| Net income | 7.15M 8.3M 6.71M 6.12M 11.54M 794M 11.57M 79.59M 31.05M 401M 31.17M 30.49M 1.33B | 4.78M 5.55M 4.48M 4.09M 7.71M 530M 7.74M 53.2M 20.76M 268M 20.84M 20.38M 888M |
| Net Debt | -17.25M -20.02M -16.18M -14.77M -27.82M -1.91B -27.91M -192M -74.88M -966M -75.17M -73.54M -3.2B | -21.03M -24.41M -19.72M -18M -33.92M -2.33B -34.02M -234M -91.29M -1.18B -91.65M -89.66M -3.91B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
